BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18534764)

  • 21. Abeta amyloid deposition in the language system and how the brain responds.
    Nelissen N; Vandenbulcke M; Fannes K; Verbruggen A; Peeters R; Dupont P; Van Laere K; Bormans G; Vandenberghe R
    Brain; 2007 Aug; 130(Pt 8):2055-69. PubMed ID: 17586869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
    Meli G; Visintin M; Cannistraci I; Cattaneo A
    J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo staining characteristics of small, fluorescent, Abeta42-binding D-enantiomeric peptides in transgenic AD mouse models.
    van Groen T; Kadish I; Wiesehan K; Funke SA; Willbold D
    ChemMedChem; 2009 Feb; 4(2):276-82. PubMed ID: 19072935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta.
    Adlard PA; Cherny RA; Finkelstein DI; Gautier E; Robb E; Cortes M; Volitakis I; Liu X; Smith JP; Perez K; Laughton K; Li QX; Charman SA; Nicolazzo JA; Wilkins S; Deleva K; Lynch T; Kok G; Ritchie CW; Tanzi RE; Cappai R; Masters CL; Barnham KJ; Bush AI
    Neuron; 2008 Jul; 59(1):43-55. PubMed ID: 18614028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo targeting of antibody fragments to the nervous system for Alzheimer's disease immunotherapy and molecular imaging of amyloid plaques.
    Poduslo JF; Ramakrishnan M; Holasek SS; Ramirez-Alvarado M; Kandimalla KK; Gilles EJ; Curran GL; Wengenack TM
    J Neurochem; 2007 Jul; 102(2):420-33. PubMed ID: 17596213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.
    Abramowski D; Wiederhold KH; Furrer U; Jaton AL; Neuenschwander A; Runser MJ; Danner S; Reichwald J; Ammaturo D; Staab D; Stoeckli M; Rueeger H; Neumann U; Staufenbiel M
    J Pharmacol Exp Ther; 2008 Nov; 327(2):411-24. PubMed ID: 18687920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow-derived mesenchymal stem cells reduce brain amyloid-beta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model.
    Lee JK; Jin HK; Bae JS
    Neurosci Lett; 2009 Jan; 450(2):136-41. PubMed ID: 19084047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic transmission is impaired prior to plaque formation in amyloid precursor protein-overexpressing mice without altering behaviorally-correlated sharp wave-ripple complexes.
    Hermann D; Both M; Ebert U; Gross G; Schoemaker H; Draguhn A; Wicke K; Nimmrich V
    Neuroscience; 2009 Sep; 162(4):1081-90. PubMed ID: 19477243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease.
    Onozuka H; Nakajima A; Matsuzaki K; Shin RW; Ogino K; Saigusa D; Tetsu N; Yokosuka A; Sashida Y; Mimaki Y; Yamakuni T; Ohizumi Y
    J Pharmacol Exp Ther; 2008 Sep; 326(3):739-44. PubMed ID: 18544674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology.
    Schilling S; Zeitschel U; Hoffmann T; Heiser U; Francke M; Kehlen A; Holzer M; Hutter-Paier B; Prokesch M; Windisch M; Jagla W; Schlenzig D; Lindner C; Rudolph T; Reuter G; Cynis H; Montag D; Demuth HU; Rossner S
    Nat Med; 2008 Oct; 14(10):1106-11. PubMed ID: 18836460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative approaches to amyloid imaging.
    Villemagne VL; O'Keefe G; Mulligan RS; Rowe CC
    Methods Mol Biol; 2011; 680():201-25. PubMed ID: 21153383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implanted cannula-mediated repetitive administration of Abeta25-35 into the mouse cerebral ventricle effectively impairs spatial working memory.
    Yamada M; Chiba T; Sasabe J; Nawa M; Tajima H; Niikura T; Terashita K; Aiso S; Kita Y; Matsuoka M; Nishimoto I
    Behav Brain Res; 2005 Nov; 164(2):139-46. PubMed ID: 16122819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring blood flow alterations in the Tg2576 mouse model of Alzheimer's disease by in vivo magnetic resonance angiography at 17.6 T.
    Kara F; Dongen ES; Schliebs R; Buchem MA; Groot HJ; Alia A
    Neuroimage; 2012 Apr; 60(2):958-66. PubMed ID: 22227054
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance markers for early diagnosis and progression of Alzheimer's disease.
    Kantarci K
    Expert Rev Neurother; 2005 Sep; 5(5):663-70. PubMed ID: 16162090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship of chalcones and related derivatives as ligands for detecting of beta-amyloid plaques in the brain.
    Ono M; Hori M; Haratake M; Tomiyama T; Mori H; Nakayama M
    Bioorg Med Chem; 2007 Oct; 15(19):6388-96. PubMed ID: 17644339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative evaluation of MRI and histological characteristics of the 5xFAD Alzheimer mouse brain.
    Spencer NG; Bridges LR; Elderfield K; Amir K; Austen B; Howe FA
    Neuroimage; 2013 Aug; 76():108-15. PubMed ID: 23507393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI.
    Gong NJ; Dibb R; Bulk M; van der Weerd L; Liu C
    Neuroimage; 2019 May; 191():176-185. PubMed ID: 30739060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice.
    Wu EX; Tang H; Asai T; Yan SD
    Neurosci Lett; 2004 Jul; 365(3):223-7. PubMed ID: 15246553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease.
    Prvulovic D; Bokde AL; Faltraco F; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):557-69. PubMed ID: 21722703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.